Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine + granisetron + dexamethasone for prevention of carboplatin-induced nausea and vomiting in thoracic cancer
jRCTs041220042Phase 2Completed
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mirtazapine in chemotherapy-induced nausea and vomiting (CINV). Started Aug 2022; status: completed.
02
Drugs
mirtazapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on jRCTs041220042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041220042.